Lofibra 134 mg Gate 323 Pill - blue capsule/oblong, 18mm
Generic Name: fenofibrate
Pill with imprint Lofibra 134 mg Gate 323 is Blue, Capsule/Oblong and has been identified as Lofibra 134 mg. It is supplied by Gate Pharmaceuticals.
Lofibra is used in the treatment of Hypertriglyceridemia; Hyperlipoproteinemia; Hyperlipoproteinemia Type IIa, Elevated LDL; Hyperlipoproteinemia Type IV, Elevated VLDL; Hyperlipoproteinemia Type IIb, Elevated LDL VLDL and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Lofibra 134 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Lofibra 134 mg Gate 323
Lofibra
- Generic Name
- fenofibrate
- Imprint
- Lofibra 134 mg Gate 323
- Strength
- 134 mg
- Color
- Blue
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gate Pharmaceuticals
- National Drug Code (NDC)
- 57844-0323 (Discontinued)
- Inactive Ingredients
-
croscarmellose sodium,
lactose monohydrate,
magnesium stearate,
povidone k25,
corn starch,
sodium lauryl sulfate,
magnesium silicate,
D&C Red No. 28,
FD&C Blue No. 1,
titanium dioxide
Note: Inactive ingredients may vary.
More about Lofibra (fenofibrate)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: fibric acid derivatives
- Breastfeeding
Patient resources
Other brands
TriCor, Triglide, Antara, Fenoglide, Lipofen
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.